Mario Vaneechoutte
Overview
Explore the profile of Mario Vaneechoutte including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
207
Citations
5694
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Himschoot L, Mulinganya G, Rogier T, Bisimwa G, Kampara F, Kujirakwinja Y, et al.
Front Cell Infect Microbiol
. 2025 Feb;
14:1514884.
PMID: 39897482
Background: is a key pathogen in bacterial vaginosis (BV), but the role of the different species remains unclear. We investigated the role of four species, as well as , and...
2.
Van Overfelt S, Duyvejonck H, Baeke F, De Rycke R, Merabishvili M, Vermeulen S, et al.
PLoS One
. 2024 Dec;
19(12):e0313774.
PMID: 39625917
To use phages in a personalized therapy and industrial applications, an accurate quantification is needed. The gold standard method, namely the culture-based double agar overlay (DAO) method, provides an accurate...
3.
Versmessen N, Mispelaere M, Vandekerckhove M, Hermans C, Boelens J, Vranckx K, et al.
Diagnostics (Basel)
. 2024 Aug;
14(16).
PMID: 39202288
Whole-genome sequencing (WGS) is revolutionizing clinical bacteriology. However, bacterial typing remains investigated by reference techniques with inherent limitations. This stresses the need for alternative methods providing robust and accurate sequence...
4.
Swidsinski A, Amann R, Guschin A, Swidsinski S, Loening-Baucke V, Mendling W, et al.
Microbes Infect
. 2024 Aug;
26(8):105403.
PMID: 39127090
The manuscript disputes the exclusive mono-infectious way of thinking, which presumes that for every infection only one pathogen is responsible and sufficient, when infectious vectors, close contact and reduced immunity...
5.
Versmessen N, Van Simaey L, Negash A, Vandekerckhove M, Hulpiau P, Vaneechoutte M, et al.
PLoS One
. 2024 Jun;
19(6):e0305650.
PMID: 38885212
Accurate DNA quantification is key for downstream application including library preparations for whole genome sequencing (WGS) and the quantification of standards for quantitative PCR. Two commonly used technologies for nucleic...
6.
Mulinganya M, De Keyser K, Mongane I, Kampara M, De Vulder A, Boelens J, et al.
Front Glob Womens Health
. 2024 Jun;
5:1339821.
PMID: 38847001
Introduction: Vaginal colonization (CC) can lead to vulvovaginal candidiasis, the second most prevalent vaginal condition worldwide, and has been associated with adverse birth outcomes. However, no data on CC in...
7.
Hovhannisyan H, Rodriguez A, Saus E, Vaneechoutte M, Gabaldon T
Front Cell Infect Microbiol
. 2023 Feb;
13:1093178.
PMID: 36761895
The study of transcriptomic interactions between host and pathogens in conditions is challenged by the low relative amounts of the pathogen RNA. Yeast opportunistic pathogens of the genus can cause...
8.
Rosca A, Castro J, Sousa L, Franca A, Vaneechoutte M, Cerca N
J Antimicrob Chemother
. 2022 May;
77(8):2183-2190.
PMID: 35578895
Background: Bacterial vaginosis (BV), the most common cause of vaginal discharge, is characterized by the presence of a polymicrobial biofilm on the vaginal epithelium, formed primarily by Gardnerella spp., but...
9.
Landlinger C, Oberbauer V, Podpera Tisakova L, Schwebs T, Berdaguer R, Van Simaey L, et al.
Antimicrob Agents Chemother
. 2022 Apr;
66(5):e0231921.
PMID: 35416708
Antibiotics are the mainstay of therapy for bacterial vaginosis (BV). However, the rate of treatment failure in patients with recurrent BV is about 50%. Herein, we investigated potential mechanisms of...
10.
Latka A, Van Simaey L, Reynders M, Cools P, Rogier T, Lebbe B, et al.
Antibiotics (Basel)
. 2022 Jan;
11(1).
PMID: 35052988
Quantification of the number of living cells in biofilm or after eradication treatments of biofilm, is problematic for different reasons. We assessed the performance of pre-treatment of DNA, planktonic cells...